Resolution of disease symptoms in patients treated with quetiapine for acute moderate to severe schizophrenia

被引：0
|
作者：
Peuskens, J. [1 ]
Mourad, H. [2 ]
Kusters, J. [3 ]
Vandenhoven, G. [4 ]
机构：
[1] Univ Centrum St Josef, Kortenberg, Belgium
[2] CHP, Agora Petit Bourgogne, Liege, Belgium
[3] Psychiat Ziekenhuis, Tuiden, Belgium
[4] Astrazeneca, Brussels, Belgium
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2007年 / 17卷
关键词：
D O I：
10.1016/S0924-977X(07)70615-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S411 / S411
页数：1
相关论文
共 50 条
  • [21] Sleep quality and architecture in quetiapine, risperidone, or never-treated schizophrenia patients
    Keshavan, Matcheri S.
    Prasad, Konasale M.
    Montrose, Debra M.
    Miewald, Jean M.
    Kupfer, David J.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (06) : 703 - 705
  • [22] COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab
    Ungar, Benjamin
    Glickman, Jacob W.
    Golant, Alexandra K.
    Dubin, Celina
    Marushchak, Olga
    Gontzes, Alyssa
    Mikhaylov, Daniela
    Singer, Giselle K.
    Baum, Danielle
    Wei, Nancy
    Sanin, Antonio
    Gruenstein, Diana
    Lebwohl, Mark G.
    Pavel, Ana B.
    Guttman-Yassky, Emma
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (01): : 134 - 142
  • [23] A non-interventional naturalistic study to evaluate efficacy of quetiapine in terms of 'resolution' of symptoms of schizophrenia.
    Falkai, Peter
    Klein, P.
    Koehler, J.
    NERVENARZT, 2007, 78 : 84 - 84
  • [24] Prolactin levels and symptoms of hyperprolactinemia in patients treated with amisulpride, risperidone, olanzapine and quetiapine
    Fric, M
    Laux, G
    PSYCHIATRISCHE PRAXIS, 2003, 30 : S97 - S101
  • [25] ANALYSIS OF THE EFFECT OF MEMANTINE IN REDUCING CLINICAL SYMPTOMS IN PATIENTS WITH MODERATE TO SEVERE ALZHEIMER'S DISEASE
    Moruzzi, E.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [26] Gastrointestinal Signs and Symptoms Related to Inflammatory Bowel Disease in Patients With Moderate-to-Severe Psoriasis
    Feldman, Steven R.
    Srivastava, Bhaskar
    Abell, Jill
    Hoops, Timothy
    Fakharzadeh, Steve
    Chakravarty, Soumya D.
    Muser, Erik
    Dungee, Danielle
    Quinn, Sean T.
    Leone-Perkins, Megan
    Kappelman, Michael D.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2018, 17 (12) : 1298 - 1308
  • [27] Specific benefits of memantine on behavioural symptoms in patients with moderate to severe Alzheimer's disease (AD)
    Gauthier, S.
    Cummings, J. L.
    Loft, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 49 - 49
  • [28] Efficacy of donepezil on functional, behavioral, and cognitive symptoms in patients with moderate to severe Alzheimer's disease
    Gauthier, S
    Feldman, H
    Hecker, J
    Vellas, B
    Subbiah, P
    Whalen, E
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (08) : S2 - S2
  • [29] High prevalence of depression and anxiety symptoms in early rheumatoid arthritis patients with moderate to severe disease
    Chang, D.
    Robertson, D.
    Mscisz, T.
    Singh, A.
    Freundlich, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 345 - 345
  • [30] Pharmacogenetics and cognitive symptoms in schizophrenia patients treated with antipsychotics
    Musil, Richard
    Spellmann, Ilja
    PHARMACOGENOMICS, 2018, 19 (12) : 927 - 930
12345